Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2
Open Access
- 17 March 2008
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 27 (30) , 4200-4209
- https://doi.org/10.1038/onc.2008.58
Abstract
Tumor hypoxia has been reported to cause a functional loss in DNA mismatch repair (MMR) system as a result of downregulation of MMR genes, although the precise molecular mechanisms remain unclear. In this study, we focused on the downregulation of a key MMR gene, MLH1, and demonstrated that hypoxia-inducible transcription repressors, differentiated embryo chondrocytes (DEC1 and 2), participated in its transcriptional regulation via their bindings to E-box-like motif(s) in MLH1 promoter region. In all cancer cell lines examined, hypoxia increased expression of DEC1 and 2, known as hypoxia-inducible genes, but decreased MLH1 expression in an exposure time-dependent manner at both the mRNA and protein levels. Co-transfection reporter assay revealed that DEC1 and, to greater extent, DEC2 as well as hypoxia-repressed MLH1 promoter activity. We further found that the action was remarkably inhibited by trichostatin A, and identified a possible DEC-response element in the MLH1 promoter. In vitro electrophoretic gel mobility shift and chromatin immunoprecipitation assays demonstrated that DEC1 or 2 directly bounds to the suggested element, and transient transfection assay revealed that overexpression of DEC2 repressed endogenous MLH1 expression in the cells. Hypoxia-induced DEC may impair MMR function through repression of MLH1 expression, possibly via the histone deacethylase-mediated mechanism in cancer cells.Keywords
This publication has 26 references indexed in Scilit:
- Co-repression of mismatch repair gene expression by hypoxia in cancer cells: Role of the Myc/Max networkPublished by Elsevier ,2007
- Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor MicroenvironmentMolecular Cancer Research, 2006
- Hypoxia-Induced Down-regulation of BRCA1 Expression by E2FsCancer Research, 2005
- Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer CellsMolecular and Cellular Biology, 2004
- Investigating hypoxic tumor physiology through gene expression patternsOncogene, 2003
- Dec1 and Dec2 are regulators of the mammalian molecular clockNature, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Genome maintenance mechanisms for preventing cancerNature, 2001
- Regulation of STRA13 by the von Hippel-Lindau Tumor Suppressor Protein, Hypoxia, and the UBC9/Ubiquitin Proteasome Degradation PathwayJournal of Biological Chemistry, 2001
- Molecular Cloning and Characterization of DEC2, a New Member of Basic Helix-Loop-Helix ProteinsBiochemical and Biophysical Research Communications, 2001